Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1970 Jan;25(1):86–88. doi: 10.1136/thx.25.1.86

Haemodynamic effects of dextro-propranolol in acute myocardial infarction

David Bennet 1, Raphael Balcon 1, Judith Hoy 1, Edgar Sowton 1,1
PMCID: PMC472126  PMID: 4392113

Abstract

Intravenous injections of 20-25 mg. d-propranolol did not change the heart rate or systemic pressure in 13 patients with cardiac infarction. Cardiac output was depressed in 10, but there was no clinical deterioration. d-Propranolol was better tolerated than dl-propranolol under these conditions and justifies further investigation as an anti-dysrhythmic agent. The major depressant effects of dl-propranolol following cardiac infarction appear to be due to beta-adrenergic blockade and not to a direct depressant action on cardiac muscle.

Full text

PDF
86

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Balcon R., Hoy J., Sowton E. Haemodynamic effects of rapid digitalization following acute myocardial infarction. Br Heart J. 1968 May;30(3):373–376. doi: 10.1136/hrt.30.3.373. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Barrett A. M. A comparison of the effects of (plus of minus)-propranolol and (plus)-propranolol in anaesthetized dogs; beta-receptor blocking and haemodynamic action. J Pharm Pharmacol. 1969 Apr;21(4):241–247. doi: 10.1111/j.2042-7158.1969.tb08239.x. [DOI] [PubMed] [Google Scholar]
  3. Bay G., Lund-Larsen P., Lorentsen E., Sivertssen E. Haemodynamic effects of propranolol (Inderal) in acute myocardial infarction. Br Med J. 1967 Jan 21;1(5533):141–143. doi: 10.1136/bmj.1.5533.141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Frieden J. Propranolol as an antiarrhythmic agent. Am Heart J. 1967 Aug;74(2):283–285. doi: 10.1016/0002-8703(67)90291-8. [DOI] [PubMed] [Google Scholar]
  5. Gettes L. S., Surawicz B. Long-term prevention of paroxysmal arrhythmias with propranolol therapy. Am J Med Sci. 1967 Sep;254(3):257–265. [PubMed] [Google Scholar]
  6. Gibson D., Sowton E. The use of beta-adrenergic receptor blocking drugs in dysrhythmias. Prog Cardiovasc Dis. 1969 Jul;12(1):16–39. doi: 10.1016/0033-0620(69)90033-4. [DOI] [PubMed] [Google Scholar]
  7. Howe R., Shanks R. G. Optical isomers of propranolol. Nature. 1966 Jun 25;210(5043):1336–1338. doi: 10.1038/2101336a0. [DOI] [PubMed] [Google Scholar]
  8. Howitt G., Husaini M., Rowlands D. J., Logan W. F., Shanks R. G., Evans M. G. The effect of the dextro isomer of propranolol on sinus rate and cardiac arrhythmias. Am Heart J. 1968 Dec;76(6):736–745. doi: 10.1016/0002-8703(68)90258-5. [DOI] [PubMed] [Google Scholar]
  9. SLOMAN G., ROBINSON J. S., MCLEAN K. PROPRANOLOL (INDERAL) IN PERSISTENT VENTRICULAR FIBRILLATION. Br Med J. 1965 Apr 3;1(5439):895–896. doi: 10.1136/bmj.1.5439.895. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Stannard M., Sloman G., Sangster L. The haemodynamic effects of atropine combined with propranolol in acute myocardial infarction. Med J Aust. 1968 Mar 2;1(9):333–334. doi: 10.5694/j.1326-5377.1968.tb28539.x. [DOI] [PubMed] [Google Scholar]
  11. Whitsitt L. S., Lucchesi B. R. Effects of propranolol and its stereoisomers upon coronary vascular resistance. Circ Res. 1967 Sep;21(3):305–317. doi: 10.1161/01.res.21.3.305. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES